November 6: Alternative Economic Assessment for Expressing Healthcare Value and Informing Resource Allocation Decisions - In Person at ISPOR Europe 2022
Various stakeholders are involved in the funding, decision-making, policy making and delivery of effective healthcare. Each of these areas requires different perspectives and constraints that can’t be addressed by applying a single perspective modeling framework such as conventional cost-effectiveness analysis. Increasingly, alternative methodological frameworks are required for informing stakeholders outside of the HTA process regarding healthcare and how to inform decisions considering known constraints including budget. This course will discuss different established economic frameworks for assessing economic value. Firstly, faculty will explore fiscal health modeling (FHM) which reflects the government perspective on population health and investments in medical technologies. Specifically, the course will cover how government can benefit from investments in healthcare based on future changes in tax revenue and reduced transfer costs attributed to changes in health status. The course will also cover constrained optimization modeling which considers that decision-making is often made under specific constraints including budget, logistics, compliance, among other features. Thirdly, faculty will discuss the social accounting matrix (SAM) analytic framework which reflects multiple perspectives simultaneously and is used in developed and developing countries for assessing new budget policies. In the context of health, we apply SAM to understand how money flows through different economic sectors based on investments in healthcare. The course will discuss the strengths and weaknesses of these different frameworks and applications in resource allocation decisions. The course outline will follow the recently completed work of the ISPOR Task Force on Economic Analysis of Vaccination Programs Chaired by Josephine Mauskopf and Baudouin Standaert and published in Value in Health. Participants who wish to gain hands-on experience must bring their personal laptops with Microsoft Excel for Windows installed.
Senior Research Scientist
Department of Pharmacy
University of Groningen
Groningen, The Netherlands
Nikolaos Kotsopoulos, PhD
Researcher
Health Policy Institute
Athens, Greece
Baudouin Standaert, MD, PhD
Guest Professor
Faculty of Medicine and Life Sciences
University of Hasselt
Hasselt, Belgium
Rachel Russell, PhD
UK Health & Value HTA Team Leader
Pfizer Ltd
Walton Oaks, Tadworth, UK
November 6, 2022
Back to all short courses
Alternative Economic Assessment for Expressing Healthcare Value and Informing Resource Allocation Decisions
LEVEL: Introductory
TRACK: Health Policy & Regulatory
LENGTH: 4 Hours | Course runs 1 day
This short course will be offered in-person at the ISPOR Europe 2022 conference. Separate registration is required. Visit the ISPOR Europe 2022 website to register and learn more.
DESCRIPTION
Various stakeholders are involved in the funding, decision-making, policy making and delivery of effective healthcare. Each of these areas requires different perspectives and constraints that can’t be addressed by applying a single perspective modeling framework such as conventional cost-effectiveness analysis. Increasingly, alternative methodological frameworks are required for informing stakeholders outside of the HTA process regarding healthcare and how to inform decisions considering known constraints including budget. This course will discuss different established economic frameworks for assessing economic value. Firstly, faculty will explore fiscal health modeling (FHM) which reflects the government perspective on population health and investments in medical technologies. Specifically, the course will cover how government can benefit from investments in healthcare based on future changes in tax revenue and reduced transfer costs attributed to changes in health status. The course will also cover constrained optimization modeling which considers that decision-making is often made under specific constraints including budget, logistics, compliance, among other features. Thirdly, faculty will discuss the social accounting matrix (SAM) analytic framework which reflects multiple perspectives simultaneously and is used in developed and developing countries for assessing new budget policies. In the context of health, we apply SAM to understand how money flows through different economic sectors based on investments in healthcare. The course will discuss the strengths and weaknesses of these different frameworks and applications in resource allocation decisions. The course outline will follow the recently completed work of the ISPOR Task Force on Economic Analysis of Vaccination Programs Chaired by Josephine Mauskopf and Baudouin Standaert and published in Value in Health. Participants who wish to gain hands-on experience must bring their personal laptops with Microsoft Excel for Windows installed.FACULTY MEMBERS
Mark Connolly, PhDSenior Research Scientist
Department of Pharmacy
University of Groningen
Groningen, The Netherlands
Nikolaos Kotsopoulos, PhD
Researcher
Health Policy Institute
Athens, Greece
Baudouin Standaert, MD, PhD
Guest Professor
Faculty of Medicine and Life Sciences
University of Hasselt
Hasselt, Belgium
Rachel Russell, PhD
UK Health & Value HTA Team Leader
Pfizer Ltd
Walton Oaks, Tadworth, UK
Basic Schedule:
4 Hours | Course runs 1 Day